Alcaliber Revenue and Competitors
Estimated Revenue & Valuation
- Alcaliber's estimated annual revenue is currently $29.3M per year.
- Alcaliber's estimated revenue per employee is $201,000
Employee Data
- Alcaliber has 146 Employees.
- Alcaliber grew their employee count by -5% last year.
Alcaliber's People
Name | Title | Email/Phone |
---|
Alcaliber Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $19.7M | 98 | 5% | N/A | N/A |
#2 | $19.7M | 98 | 42% | N/A | N/A |
#3 | $10.5M | 52 | -17% | N/A | N/A |
#4 | $32.4M | 161 | 11% | N/A | N/A |
#5 | $49M | 244 | 6% | N/A | N/A |
#6 | $7.2M | 36 | N/A | N/A | N/A |
#7 | $36.8M | 183 | 9% | N/A | N/A |
#8 | $44.8M | 223 | 13% | N/A | N/A |
#9 | $147.9M | 736 | 10% | N/A | N/A |
#10 | $29.3M | 146 | -5% | N/A | N/A |
What Is Alcaliber?
Alcaliber S.A. is a pharmaceuticals company based out of 3 Calle General Moscardó, Madrid, Community of Madrid, Spain.
keywords:N/AN/A
Total Funding
146
Number of Employees
$29.3M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Alcaliber News
2022-04-20 - Global Morphine Market 2022-2028 Demand, Key Regions ...
Alcaliber; Purdue Pharma; Sanofi Winthrop Industrie; Macfarlan Smith; Sun Pharmaceutical Industries; Qinghai Pharmaceutical; Northeast...
2022-04-19 - Global Morphine Market 2022 Industry Insights and Major ...
Alcaliber; Purdue Pharma; Sanofi Winthrop Industrie; Macfarlan Smith; Sun Pharmaceutical Industries; Qinghai Pharmaceutical; Northeast...
2022-04-19 - Thebaine Consumption Market Growth 2022-2029| Key ...
Noramco; Alcaliber; Tasmanian Alkaloids; TPI; Cepia-Sanofi; Taj Pharmaceuticals; API Labs; Faran Shimi Pharmaceuticals; Gansu Alkaloids; Hwells.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $23.3M | 146 | -1% | N/A |
#2 | $52.2M | 146 | 32% | N/A |
#3 | N/A | 147 | 31% | N/A |
#4 | $35.6M | 147 | 0% | N/A |
#5 | $23.6M | 148 | 22% | N/A |